PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 12, 2024Journal of Nuclear Medicine3 citations

Dual Somatostatin Receptor/18F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors

View Full Paper
UMUr MetserJNJose E. NuñezDCDavid Chan

Key Points

Key points are not available for this paper at this time.

Abstract

Our purpose was to prospectively assess the distribution of NETPET scores in well-differentiated (WD) grade 2 and 3 gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and to determine the impact of the NETPET score on clinical management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Metser et al. (2024) studied this question.

synapsesocial.com/papers/68e58a69b6db643587526cb1https://doi.org/10.2967/jnumed.124.267982
Ask AI
Helpful
Bookmark
Share
View Full Paper